Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbohydrate-binding module 17 (CBM17) is a non-catalytic protein domain found in various bacterial carbohydrate-active enzymes, particularly family 5 glycoside hydrolases such as endoglucanases [1, 2]. It belongs to the type-B CBM category, which is characterized by a shallow binding cleft that specifically recognizes and binds to the beta-1,4-glucan chains of non-crystalline (amorphous) cellulose and soluble cellooligosaccharides [3, 14]. Structurally, CBM17 adopts a beta-sandwich fold, often stabilized by calcium ions, and utilizes aromatic and polar amino acid residues to facilitate substrate interaction through CH-pi stacking and hydrogen bonding [14, 30]. Its primary biological function is to anchor the associated catalytic enzyme to the carbohydrate substrate, thereby increasing the local concentration of the enzyme and enhancing the efficiency of polysaccharide degradation [1, 35]. While CBM17 is not a direct therapeutic target for human diseases, it is extensively utilized in biotechnology as a molecular probe for visualizing cellulose accessibility in plant cell walls [18, 31]. Furthermore, it is a key component in the development of "designer" enzymes and multi-enzyme complexes for biomass conversion and biofuel production [20, 34]. Recent research has also explored its use as a targeting moiety in drug delivery systems for treating bacterial biofilms, although it does not currently interact with any approved pharmaceutical drugs [21]. It is primarily found in cellulolytic bacteria such as Clostridium cellulovorans and Bacillus species [6, 7].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbohydrate-binding module 17 (CBM17).